Rachel B. Slayton
Centers for Disease Control and Prevention(US)Centers for Disease Control and Prevention(UG)
Publications by Year
Research Areas
COVID-19 epidemiological studies, Antibiotic Use and Resistance, SARS-CoV-2 and COVID-19 Research, Antibiotic Resistance in Bacteria, Vaccine Coverage and Hesitancy
Most-Cited Works
- → SARS-CoV-2 Transmission From People Without COVID-19 Symptoms(2021)1,101 cited
- → Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021(2021)707 cited
- Vital signs: improving antibiotic use among hospitalized patients.(2014)
- → The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)(2012)207 cited
- → Ensemble Forecasts of Coronavirus Disease 2019 (COVID-19) in the U.S.(2020)179 cited
- → Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021(2021)163 cited
- → Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States(2015)